Hughes T - Search Results

1

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA; IRIS Investigators. Druker BJ, et al. Among authors: hughes t. N Engl J Med. 2006 Dec 7;355(23):2408-17. doi: 10.1056/NEJMoa062867. N Engl J Med. 2006. PMID: 17151364 Free article. Clinical Trial.

2

Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning.

Cullis JO, Schwarer AP, Hughes TP, Hows JM, Franklin I, Morgenstern G, Goldman JM. Cullis JO, et al. Among authors: hughes tp. Br J Haematol. 1992 Jan;80(1):33-9. doi: 10.1111/j.1365-2141.1992.tb06397.x. Br J Haematol. 1992. PMID: 1536808

3

Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation.

Cullis JO, Jiang YZ, Schwarer AP, Hughes TP, Barrett AJ, Goldman JM. Cullis JO, et al. Among authors: hughes tp. Blood. 1992 Mar 1;79(5):1379-81. Blood. 1992. PMID: 1536963 Free article. No abstract available.

4

p53 in chronic myeloid leukemia cell lines.

Bi S, Hughes T, Bungey J, Chase A, de Fabritiis P, Goldman JM. Bi S, et al. Among authors: hughes t. Leukemia. 1992 Aug;6(8):839-42. Leukemia. 1992. PMID: 1640738

5

Persistence of BCR/ABL transcripts after BMT for CML detected by PCR reflects a high risk of relapse.

Hughes TP, O'Shea P, Morgan G, Martiat P, Goldman JM. Hughes TP, et al. Bone Marrow Transplant. 1991;7 Suppl 2:23. Bone Marrow Transplant. 1991. PMID: 1878700 No abstract available.

6

Improved results with PCR for chronic myeloid leukaemia.

Hughes T, Goldman JM. Hughes T, et al. Lancet. 1990 Sep 29;336(8718):812. doi: 10.1016/0140-6736(90)93275-t. Lancet. 1990. PMID: 1976169 Clinical Trial. No abstract available.

7

Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse.

Hughes TP, Morgan GJ, Martiat P, Goldman JM. Hughes TP, et al. Blood. 1991 Feb 15;77(4):874-8. Blood. 1991. PMID: 1993225 Free article.

8

Detection and significance of minimal residual disease in patients with leukaemia and lymphoma.

Goldman JM, Hughes T. Goldman JM, et al. Among authors: hughes t. Bone Marrow Transplant. 1991;7 Suppl 1:66-9. Bone Marrow Transplant. 1991. PMID: 2043891 Review. No abstract available.

9

Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.

Mackinnon S, Hows JM, Goldman JM, Arthur CK, Hughes T, Apperley JF, Jones L, Batchelor JR, Brookes P, Catovsky D, et al. Mackinnon S, et al. Among authors: hughes t. Exp Hematol. 1990 Jun;18(5):421-5. Exp Hematol. 1990. PMID: 2338131

10

Biological importance of residual leukaemic cells after BMT for CML: does the polymerase chain reaction help?

Hughes TP, Goldman JM. Hughes TP, et al. Bone Marrow Transplant. 1990 Jan;5(1):3-6. Bone Marrow Transplant. 1990. PMID: 2404529 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,030 results

Search Page

Filters